Wang, Chencai
Van Dyk, Kathleen
Cho, Nicholas
Raymond, Catalina
Choi, Justin
Salamon, Noriko
Pope, Whitney B.
Lai, Albert
Cloughesy, Timothy F.
Nghiemphu, Phioanh L.
Ellingson, Benjamin M.
Funding for this research was provided by:
National Cancer Institute (1P50CA211015-01A1, 1R21CA223757-01, K08CA241337)
National Institute of General Medical Sciences (T32 GM008042)
IGN Foundation
Article History
Accepted: 5 July 2021
First Online: 5 August 2021
Declarations
:
: All procedures involving human participants were in accordance with the ethical standards of UCLA Institutional Review Board (IRB#11-001876; Medical IRB Committee #3; University of California Los Angeles). All analyses were done in compliance with the Health Insurance Portability and Accountability Act (HIPAA), and the UCLA IRB approved all aspects of the current study.
: Patients were recruited from the Neuro-Oncology clinic at UCLA, and all patients provided written informed consent approved by the UCLA Institutional Review Board (IRB#11-001876; Medical IRB Committee #3; University of California Los Angeles).
: All investigators have provided consent to publish this work.
: Timothy F. Cloughesy reports advisory roles with Roche, Trizel, Medscape, Bayer, Amgen, Odonate Therapeutics, Pascal Biosciences, Bayer, Del Mar Pharmaceuticals, Tocagen, Karyopharm, GW Pharma, Kiyatec, Abbvie, Boehinger Ingelheim, VBI, Deciphera, VBL, Agios, Merck, Roche, Genocea, Celgene, Puma, Lilly, BMS, Cortice, Wellcome Trust, Novocure, Novogen, Boston Biomedical, Sunovion, Human Longevity, Insys, ProNai, Pfizer, Notable labs, Medqia. Stock options with Notable Labs. Member of the board for the 501c3 Global Coalition for Adaptive Research. U.S. Provisional Application No.: 62/819,322 Title: COMPOSITIONS AND METHODS FOR TREATING CANCER.Benjamin M. Ellingson reports advisory and consulting roles with MedQIA, Roche, Agios, Siemens, Medicenna, Imaging Endpoints, Novogen, Northwest Biopharmaceuticals, Image Analysis Groupm Concoceutics, BeiGene, VBL, and Tocagen. Dr. Ellingson also has research grants with Siemens, Roche, and Janssen.All other authors declare no conflicts of interest related to the subject matter in this publication.